GIANT BioSystems
Biotechnology Research • 
570 Westwood Plaza, Magnify at CNSI, United States • 1-10 Employees
Company overview
| Headquarters | 570 Westwood Plaza, Magnify at CNSI, Los Angeles, California 90095, US |
| Website | |
| NAICS | 541714 |
| Keywords | Healthcare, Sepsis, Drug Screening, Diagnostics, Antimicrobial Resistance, Antibiotic Stewardship |
| Founded | 2023 |
| Employees | 1-10 |
Key Contact at GIANT BioSystems
Morteza Azizi
Chief Technology Officer (CTO) & Co-Founder
About GIANT BioSystems
GIANT BioSystems is revolutionizing antimicrobial susceptibility testing (AST) and drug screening with its groundbreaking microfluidic platform, addressing the urgent need for rapid, low-cost, and precise diagnostics. Traditional AST methods delay appropriate antibiotic adjustments, jeopardizing patient outcomes, increasing mortality rates, and contributing to antimicrobial resistance (AMR). GIANT BioSystems’ platform delivers ultrafast and actionable AST results within just 2-4 hours, significantly faster than conventional methods (2-5 days), enabling precise antibiotic interventions that improve patient care.
GIANT BioSystems revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
GIANT BioSystems has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
GIANT BioSystems has never raised funding before.
Canada
Sweden
Hong Kong
United Kingdom
Frequently asked questions
4.8
40,000 users
